Early Aubagio ‘preferable for preventing disease progression’
Early Aubagio reduces disability progression more significantly than delayed treatment in patients with multiple sclerosis (MS), according to results from the phase three TOWER study and its open-label extension phase, presented at the 2015 Annual Meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)... Read more - http://www.ms-uk.org/MSnews
Early Aubagio ‘preferable for preventing disease progression
Early Aubagio ‘preferable for preventing disease progression
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2511 Views
-
Last post by NHE
-
- 0 Replies
- 1238 Views
-
Last post by frodo
-
- 0 Replies
- 1122 Views
-
Last post by NHE
-
- 0 Replies
- 1337 Views
-
Last post by frodo
-
- 0 Replies
- 1472 Views
-
Last post by NHE
-
- 0 Replies
- 1207 Views
-
Last post by frodo
-
- 0 Replies
- 1537 Views
-
Last post by NHE
-
- 0 Replies
- 1825 Views
-
Last post by DIM
-
- 0 Replies
- 1463 Views
-
Last post by NHE